Literature DB >> 2468461

Immunocytochemical presentation of alpha-fetoprotein-producing gastric cancer in ascitic fluid: a case study.

T K Kobayashi1, T Gotoh, M Kamachi, S Watanabe, I Sawaragi.   

Abstract

A case of primary gastric cancer without hepatic metastasis showing extremely high alpha-fetoprotein (AFP) levels is reported. This case illustrates the application of the immuno-peroxidase technique to ascitic fluid cytology. Papanicolaou-stained smears of the ascites permitted the diagnosis of a metastatic carcinoma. A positive reaction to AFP was demonstrated in the tumor cells in the ascitic fluid cellular samples as well as in the paraffin-embedded tissue section of the primary gastric carcinoma. Rising AFP levels were also detected in ascitic fluid. AFP fractionation using lectin-affinity-crossed-line immunoelectrophoresis showed the hepatic rather than yolk sac type. Reports of such occurrences are few; no study, to the best of our knowledge, has previously documented cytological and immunocytochemical diagnosis in ascitic fluid. AFP-producing gastric cancer should be considered in the differential diagnosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2468461     DOI: 10.1002/dc.2840040207

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  3 in total

Review 1.  Metastatic Carcinoma in Effusions.

Authors:  Vinod B Shidham
Journal:  Cytojournal       Date:  2022-01-31       Impact factor: 2.345

2.  Hepatoid Adenocarcinoma of Stomach: Emphasis on the Clinical Relationship with Alpha-Fetoprotein-Positive Gastric Cancer.

Authors:  Er-Bao Chen; Yi-Chou Wei; Hai-Ning Liu; Cheng Tang; Meng-Ling Liu; Ke Peng; Tianshu Liu
Journal:  Biomed Res Int       Date:  2019-12-13       Impact factor: 3.411

3.  Effect of Immune Checkpoint Inhibitors Plus Chemotherapy on Advanced Gastric Cancer Patients with Elevated Serum AFP or Hepatoid Adenocarcinoma.

Authors:  Wei Li; Qian Li; Yiyi Yu; Yan Wang; Erbao Chen; Lingli Chen; Zhiming Wang; Yuehong Cui; Tianshu Liu
Journal:  Cancer Manag Res       Date:  2020-11-02       Impact factor: 3.989

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.